Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastrointest Oncol. May 15, 2025; 17(5): 103809
Published online May 15, 2025. doi: 10.4251/wjgo.v17.i5.103809
Table 5 DeLong test results for the area under the curve of dynamic contrast-enhanced magnetic resonance imaging metrics and tumor biomarkers in differentiating T staging and degree of differentiation
Inspection results
Z-score
Significance level
AUC
Mean error
95%CI
T installment
CA19-9 and CA125 serum biomarkers0.8620.3890.0140.016-0.018 to 0.046
CA19-9 alongside DCE-MRI measurements and cancer markers4.253< 0.050.1110.0260.060 to 0.162
CA125 in conjunction with DCE-MRI parameters and tumor markers4.682< 0.050.1250.0270.072 to 0.178
Degree of differentiation
CA19-9 and CA125 serum biomarkers0.9230.3560.0180.020-0.021 to 0.057
CA19-9 alongside DCE-MRI measurements and cancer markers4.132< 0.050.1090.0260.058 to 0.160
CA125 in conjunction with DCE-MRI parameters and tumor markers4.521< 0.050.1270.0280.072 to 0.182